ddPCR Enhances early diagnosis, treatment, prognosis, and pathogen verification in elderly BSI.

IF 4.8 2区 医学 Q2 IMMUNOLOGY
Frontiers in Cellular and Infection Microbiology Pub Date : 2025-07-10 eCollection Date: 2025-01-01 DOI:10.3389/fcimb.2025.1605795
Jiayi Peng, Huili Bai, Ying Li, Huating Luo, Jiajun Li, Haifeng Dai, Hongmei Wang, Tao Meng, Jia Zhang, Zhijian Wang, Xuanxin Chen, Wei Cheng, Yan Peng, Wenxiang Huang
{"title":"ddPCR Enhances early diagnosis, treatment, prognosis, and pathogen verification in elderly BSI.","authors":"Jiayi Peng, Huili Bai, Ying Li, Huating Luo, Jiajun Li, Haifeng Dai, Hongmei Wang, Tao Meng, Jia Zhang, Zhijian Wang, Xuanxin Chen, Wei Cheng, Yan Peng, Wenxiang Huang","doi":"10.3389/fcimb.2025.1605795","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Bloodstream infection (BSI) exhibits elevated mortality, particularly among elderly patients manifesting atypical symptoms. Although blood culture (BC) remains the diagnostic gold standard, its limited sensitivity and prolonged turnaround time impede early detection. Droplet digital polymerase chain reaction (ddPCR), a novel pathogen detection method with superior sensitivity and rapid results, demonstrates significant diagnostic and prognostic for BSI. However, heightened sensitivity may increase false positive rates, with elderly patients particularly susceptible to specimen contamination and transient bacteremia.</p><p><strong>Methods: </strong>This retrospective study employed clinical judgment as the diagnostic reference. Patients were stratified into BSI and non-BSI groups, with data collected on ddPCR and BC results, imaging and laboratory findings, medication response, and discharge outcomes. The diagnostic accuracy and antibiotic guidance efficacy of ddPCR and BC were compared, and the clinical utility of ddPCR was evaluated for prognostic assessment and false positive identification.</p><p><strong>Results: </strong>The analysis encompassed 355 episodes from 280 elderly patients with suspected BSI. ddPCR demonstrated significantly higher detection rates compared to BC in BSI group (59.33% versus 20.57%). Combined implementation increased detection to 65.07%. Regardless of clinical judgment (59.61% versus 20.57%) or alternative microbiological tests (90.63% versus 7.14%) served as the reference standards, ddPCR exhibited superior sensitivity to BC. No significant differences emerged in antibiotic adjustment rates or therapeutic efficacy between ddPCR and BC. Elevated microbial species diversity correlated with unfavorable discharge outcomes (P<0.001, OR=2.122). Multiple follow-up ddPCR monitoring revealed progressive increases in the number of species and the copies of some (or all) species among patients with poor outcomes, contrasting with decreasing trends in those with favorable outcomes. When detecting <i>Streptococcus</i>, coagulase-negative <i>Staphylococci</i> (CoNS), <i>Acinetobacter baumannii</i> complex, and <i>Candida</i>, diagnostic thresholds of 132.55, 182.70/262.24, and 174.78 copies/mL, respectively, were established to help differentiate false-positive results.</p><p><strong>Conclusion: </strong>The combination of ddPCR with BC improves BSI diagnosis in elderly patients and facilitates antibiotic treatment optimization. Moreover, ddPCR demonstrates potential for prognostic evaluation and false-positive discrimination. Nevertheless, these findings require further validation through large-scale prospective studies employing predefined clinical criteria.</p>","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":"15 ","pages":"1605795"},"PeriodicalIF":4.8000,"publicationDate":"2025-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12286947/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Cellular and Infection Microbiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fcimb.2025.1605795","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Bloodstream infection (BSI) exhibits elevated mortality, particularly among elderly patients manifesting atypical symptoms. Although blood culture (BC) remains the diagnostic gold standard, its limited sensitivity and prolonged turnaround time impede early detection. Droplet digital polymerase chain reaction (ddPCR), a novel pathogen detection method with superior sensitivity and rapid results, demonstrates significant diagnostic and prognostic for BSI. However, heightened sensitivity may increase false positive rates, with elderly patients particularly susceptible to specimen contamination and transient bacteremia.

Methods: This retrospective study employed clinical judgment as the diagnostic reference. Patients were stratified into BSI and non-BSI groups, with data collected on ddPCR and BC results, imaging and laboratory findings, medication response, and discharge outcomes. The diagnostic accuracy and antibiotic guidance efficacy of ddPCR and BC were compared, and the clinical utility of ddPCR was evaluated for prognostic assessment and false positive identification.

Results: The analysis encompassed 355 episodes from 280 elderly patients with suspected BSI. ddPCR demonstrated significantly higher detection rates compared to BC in BSI group (59.33% versus 20.57%). Combined implementation increased detection to 65.07%. Regardless of clinical judgment (59.61% versus 20.57%) or alternative microbiological tests (90.63% versus 7.14%) served as the reference standards, ddPCR exhibited superior sensitivity to BC. No significant differences emerged in antibiotic adjustment rates or therapeutic efficacy between ddPCR and BC. Elevated microbial species diversity correlated with unfavorable discharge outcomes (P<0.001, OR=2.122). Multiple follow-up ddPCR monitoring revealed progressive increases in the number of species and the copies of some (or all) species among patients with poor outcomes, contrasting with decreasing trends in those with favorable outcomes. When detecting Streptococcus, coagulase-negative Staphylococci (CoNS), Acinetobacter baumannii complex, and Candida, diagnostic thresholds of 132.55, 182.70/262.24, and 174.78 copies/mL, respectively, were established to help differentiate false-positive results.

Conclusion: The combination of ddPCR with BC improves BSI diagnosis in elderly patients and facilitates antibiotic treatment optimization. Moreover, ddPCR demonstrates potential for prognostic evaluation and false-positive discrimination. Nevertheless, these findings require further validation through large-scale prospective studies employing predefined clinical criteria.

ddPCR增强了老年BSI的早期诊断、治疗、预后和病原体验证。
背景:血流感染(BSI)死亡率升高,特别是在表现出非典型症状的老年患者中。虽然血培养(BC)仍然是诊断的金标准,但其有限的灵敏度和较长的周转时间阻碍了早期发现。液滴数字聚合酶链反应(ddPCR)是一种灵敏度高、结果快速的新型病原体检测方法,对BSI的诊断和预后具有重要意义。然而,敏感性的提高可能会增加假阳性率,老年患者特别容易受到标本污染和短暂菌血症的影响。方法:回顾性研究以临床判断为诊断依据。将患者分为BSI组和非BSI组,收集ddPCR和BC结果、影像学和实验室结果、药物反应和出院结果的数据。比较ddPCR和BC的诊断准确性和抗生素指导效果,并评价ddPCR在预后评估和假阳性鉴定中的临床应用价值。结果:分析包括来自280例老年疑似BSI患者的355次发作。BSI组ddPCR的检出率明显高于BC (59.33% vs 20.57%)。联合实施使检出率提高到65.07%。无论临床判断(59.61%对20.57%)或替代微生物试验(90.63%对7.14%)作为参考标准,ddPCR对BC都表现出更高的敏感性。ddPCR和BC在抗生素调整率和治疗效果上无显著差异。与不良排放结果相关的微生物物种多样性升高(PStreptococcus,凝固酶阴性葡萄球菌(CoNS),鲍曼不动杆菌复合物和念珠菌)的诊断阈值分别为132.55,182.70/262.24和174.78拷贝/mL,以帮助区分假阳性结果。结论:ddPCR联合BC可提高老年BSI患者的诊断率,有利于优化抗生素治疗。此外,ddPCR显示了预后评估和假阳性鉴别的潜力。然而,这些发现需要通过采用预先定义的临床标准的大规模前瞻性研究进一步验证。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
7.90
自引率
7.00%
发文量
1817
审稿时长
14 weeks
期刊介绍: Frontiers in Cellular and Infection Microbiology is a leading specialty journal, publishing rigorously peer-reviewed research across all pathogenic microorganisms and their interaction with their hosts. Chief Editor Yousef Abu Kwaik, University of Louisville is supported by an outstanding Editorial Board of international experts. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide. Frontiers in Cellular and Infection Microbiology includes research on bacteria, fungi, parasites, viruses, endosymbionts, prions and all microbial pathogens as well as the microbiota and its effect on health and disease in various hosts. The research approaches include molecular microbiology, cellular microbiology, gene regulation, proteomics, signal transduction, pathogenic evolution, genomics, structural biology, and virulence factors as well as model hosts. Areas of research to counteract infectious agents by the host include the host innate and adaptive immune responses as well as metabolic restrictions to various pathogenic microorganisms, vaccine design and development against various pathogenic microorganisms, and the mechanisms of antibiotic resistance and its countermeasures.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信